Contact this trialFirst, we need to learn more about you.
Radioligand Therapy
Carboplatin + 177Lu-PSMA-617 for Prostate Cancer
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial aims to determine if a combination of chemotherapy drug, carboplatin, and radioligand treatment, 177Lu-PSMA-617, is safe and effective in treating prostate cancer
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service